[
  {
    "date": "2023-12-30",
    "symbol": "CLSD",
    "period": "FY",
    "entityregistrantname": "Clearside Biomedical, Inc.",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CLSD",
    "documenttype": "10-K",
    "entitycentralindexkey": 1539029,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-37783",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "45-2437375",
    "entityaddressaddressline1": "900 North Point Parkway",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Alpharetta",
    "entityaddressstateorprovince": "GA",
    "entityaddresspostalzipcode": 30005,
    "cityareacode": 678,
    "localphonenumber": "270-3631",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Atlanta, Georgia",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 28920000,
    "accountsreceivablenetcurrent": 170000,
    "prepaidexpensecurrent": 722000,
    "otherassetscurrent": 311000,
    "assetscurrent": 30123000,
    "propertyplantandequipmentnet": 2996000,
    "operatingleaserightofuseasset": 869000,
    "otherassetsnoncurrent": 30000,
    "assets": 34018000,
    "accountspayablecurrent": 2205000,
    "accruedliabilitiescurrent": 4169000,
    "operatingleaseliabilitycurrent": 364000,
    "deferredrevenuecurrent": 75000,
    "liabilitiescurrent": 6813000,
    "liabilitiesrelatedtothesalesoffutureroyalties": 41988000,
    "operatingleaseliabilitynoncurrent": 649000,
    "otherliabilitiesnoncurrent": 480000,
    "liabilities": 49930000,
    "commonstockvalue": 63000,
    "additionalpaidincapital": 304948000,
    "retainedearningsaccumulateddeficit": -320923000,
    "stockholdersequity": -15912000,
    "liabilitiesandstockholdersequity": 34018000,
    "accountspayablerelatedpartycurrent": 331000,
    "accruedliabilitiescurrentrelatedparty": 215000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 62850841,
    "commonstocksharesoutstanding": 62850841,
    "revenuefromcontractwithcustomerexcludingassessedtax": 8226000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2023#LicenseMember",
    "costofgoodsandservicessold": 355000,
    "researchanddevelopmentexpense": 20846000,
    "generalandadministrativeexpense": 11869000,
    "operatingexpenses": 33070000,
    "operatingincomeloss": -24844000,
    "othernonoperatingincome": 1719000,
    "noncashinterestexpenseonliabilityrelatedtosalesoffutureroyalties": 9360000,
    "netincomeloss": -32485000,
    "earningspersharebasic": -0.53,
    "earningspersharediluted": -0.53,
    "weightedaveragenumberofsharesoutstandingbasic": 61806959,
    "weightedaveragenumberofdilutedsharesoutstanding": 61806959,
    "licenseandotherrevenuefromrelatedparty": 5050000,
    "researchanddevelopmenttorelatedparty": 1109000,
    "sharesoutstanding": 62850841,
    "stockissuedduringperiodvalueatmarketsalesagreement": 2000,
    "stockissuedduringperiodsharesatmarketsalesagreement": 1589699,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 65000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 68109,
    "stockissuedduringperiodvaluestockoptionsexercised": 33000,
    "stockissuedduringperiodsharesstockoptionsexercised": 81816,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 471390,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4202000,
    "profitloss": -32485000,
    "noncashinterestexpenseonliabilityrelatedtothesalesoffutureroyalites": 9361000,
    "depreciation": 67000,
    "sharebasedcompensation": 4202000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 220000,
    "increasedecreaseinotheroperatingcapitalnet": -456000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 614000,
    "increasedecreaseindeferredrevenue": -130000,
    "netcashprovidedbyusedinoperatingactivities": -18135000,
    "paymentstoacquirepropertyplantandequipment": 1777000,
    "netcashprovidedbyusedininvestingactivities": -1777000,
    "paymentstoroyaltypurchaseandsaleagreement": 1350000,
    "proceedsfromissuanceatthemarket": 1666000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplans": 65000,
    "proceedsfromstockoptionsexercised": 33000,
    "netcashprovidedbyusedinfinancingactivities": 414000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -19498000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 28920000,
    "purchaseofpropertyandequipmentincludedinaccruedliabilities": 531000,
    "accountspayableandaccruedliabilitiestoarelatedparty": 82000,
    "restrictedcashassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAssetsCurrent",
    "royaltypurchaseandsaleagreementissuancecosts": 1862000,
    "entityincorporationdateofincorporation": "2011-05-26",
    "saleofstocknumberofsharesissuedintransaction": 1073740,
    "netproceedsfromissuanceofstock": 1100000,
    "initialproceedsfromroyaltypurchaseandsaleagreement": 33977000,
    "maintancefeesoperatinglicenseliabilitypaymentsremainderoffiscalyear": 250000,
    "maintenancefeeoperatinglicenseliabilitypaymentsduenexttwelvemonths": 250000,
    "maintenancefeeoperatinglicenseliabilitypaymentsdueyeartwo": 250000,
    "maintenancefeeoperatinglicenseliabilitypaymentsdueyearthree": 350000,
    "maintenancefeeoperatinglicenseliabilitypaymentsdueyearfour": 400000,
    "maintenancefeeoperatinglicenseliabilitypaymentsdueyearfive": 500000,
    "numberofoperatingsegments": 1,
    "milestonepaymentsreceived": 1400000,
    "upfrontpayments": 5000000,
    "propertyplantandequipmentgross": 249000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 920000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#UsefulLifeTermOfLeaseMember",
    "accruedresearchanddevelopmentexpenses": 2078000,
    "employeerelatedliabilitiescurrent": 1862000,
    "accruedprofessionalfeescurrent": 38000,
    "otheraccruedliabilitiescurrent": 191000,
    "debtinstrumentinterestrateeffectivepercentage": 0.233,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P2Y9M",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The number of shares of common stock reserved for issuance under the 2016 Plan will automatically increase on January 1 each year, through January 1, 2026, by 4% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company’s board of directors.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardincreaseinnumberofsharesreservedforissuancepercentage": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3684750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9638424,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 570024,
    "commonstockcapitalsharesreservedforfutureissuance": 348782,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.98,
    "commonstockfairmarketvaluepershare": 1.17,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 1300000,
    "allocatedsharebasedcompensationexpense": 1200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9555,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0407,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 652494,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5494746,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.28,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 2.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.83,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 3,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 2.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 363000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P7Y7M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 11000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P5Y8M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 834899,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 471390,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 156643,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 3.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 3.09,
    "deferredtaxassetsoperatinglosscarryforwards": 52657000,
    "deferredtaxassetstaxnondeductibleaccrualsaccruedexpenses": 562000,
    "deferredtaxliabilitiesrightofuseassets": 210000,
    "deferredtaxassetsleaseliability": 246000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 3339000,
    "deferredtaxliabilitiesdepreciationdifferences": 71000,
    "deferredtaxassetstaxcreditcarryforwards": 10908000,
    "royaltypurchasesandsaleagreement": 10495000,
    "deferredtaxassetsinprocessresearchanddevelopment": 5777000,
    "deferredtaxassetsvaluationallowance": 84045000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0859,
    "effectiveincometaxratereconciliationotheradjustments": -0.0144,
    "effectiveincometaxratereconciliationtaxcredits": 0.0364,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.3185,
    "effectiveincometaxratereconciliationdeductionsother": 0.0006,
    "operatinglosscarryforwards": 225900000,
    "operatinglosscarryforwardsexpirationperiod": 2034,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 7500000,
    "deferredtaxassetsoperatinglossescarryforwardsdomestic": 38000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2000,
    "unrecognizedtaxbenefits": 7520000,
    "lesseeoperatingleaseoptiontoextend": "The renewal option is not included in the calculation of the right-of-use asset and the lease liabilities as the Company is not reasonably certain if the Alpharetta, Georgia lease will be renewed.",
    "incrementalborrowingrate": 0.08,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y",
    "operatingleasecost": 339000,
    "variableleasecost": 19000,
    "shorttermleasecost": 93000,
    "operatingleasepayments": 362000,
    "operatingleaseliability": 1013000,
    "lesseeoperatingleaseliabilitypaymentsduenextrollingtwelvemonths": 378000,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyeartwo": 389000,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearthree": 367000,
    "operatingleasesfutureminimumpaymentdue": 1134000,
    "operatingleaseimputedinterest": 121000,
    "maintenancefeepaymentsduenextrollingtwelvemonths": 250000,
    "maintenancefeepaymentsdueinrollingyeartwo": 250000,
    "maintenancefeepaymentsdueinrollingyearthree": 350000,
    "maintenancefeepaymentsdueinrollingyearfour": 400000,
    "maintenancefeepaymentsdueinrollingyearfive": 500000,
    "maintenancefeepaymentsdue": 1750000,
    "firstcumulativenetsalesofproducts": 45000000,
    "maintenancefeepaymentsremainderoffiscalyear": 250000,
    "researchanddevelopmenttorealtedparty": 1100000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9865770
  },
  {
    "date": "2022-12-30",
    "symbol": "CLSD",
    "period": "FY",
    "entityregistrantname": "Clearside Biomedical, Inc.",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CLSD",
    "documenttype": "10-K",
    "entitycentralindexkey": 1539029,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityfilenumber": "001-37783",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "45-2437375",
    "entityaddressaddressline1": "900 North Point Parkway",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Alpharetta",
    "entityaddressstateorprovince": "GA",
    "entityaddresspostalzipcode": 30005,
    "cityareacode": 678,
    "localphonenumber": "270-3631",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Atlanta, Georgia",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 48258000,
    "prepaidexpensecurrent": 704000,
    "otherassetscurrent": 439000,
    "assetscurrent": 49401000,
    "propertyplantandequipmentnet": 755000,
    "operatingleaserightofuseasset": 1117000,
    "restrictedcashandcashequivalentsnoncurrent": 30000,
    "assets": 51303000,
    "accountspayablecurrent": 1050000,
    "accruedliabilitiescurrent": 4179000,
    "operatingleaseliabilitycurrent": 349000,
    "deferredrevenuecurrent": 205000,
    "liabilitiescurrent": 5783000,
    "liabilitiesrelatedtothesalesoffutureroyalties": 33977000,
    "operatingleaseliabilitynoncurrent": 936000,
    "liabilities": 40696000,
    "commonstockvalue": 61000,
    "additionalpaidincapital": 298984000,
    "retainedearningsaccumulateddeficit": -288438000,
    "stockholdersequity": -288438000,
    "liabilitiesandstockholdersequity": 51303000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 13000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2022#LicenseMember",
    "costofgoodsold": 204000,
    "researchanddevelopmentexpense": 19630000,
    "generalandadministrativeexpense": 11770000,
    "operatingexpenses": 31604000,
    "operatingincomeloss": -30277000,
    "othernonoperatingincome": 669000,
    "noncashinterestexpenseonliabilityrelatedtosalesoffutureroyalties": 3339000,
    "netincomeloss": -32947000,
    "earningspersharebasic": -0.55,
    "earningspersharediluted": -0.55,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodvalueatmarketsalesagreement": 566000,
    "stockissuedduringperiodsharesatmarketsalesagreement": 425460,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 112000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 66919,
    "stockissuedduringperiodvaluestockoptionsexercised": 17000,
    "stockissuedduringperiodsharesstockoptionsexercised": 49187,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 375331,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4884000,
    "profitloss": -32947000,
    "noncashinterestexpenseonliabilityrelatedtothesalesoffutureroyalites": 3339000,
    "depreciation": 145000,
    "sharebasedcompensation": 4884000,
    "gainlossonterminationoflease": 55000,
    "gainlossonsaleofpropertyplantequipment": -33000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -10420000,
    "increasedecreaseinotheroperatingcapitalnet": 83000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 694000,
    "increasedecreaseincontractwithcustomerliability": 205000,
    "netcashprovidedbyusedinoperatingactivities": -13365000,
    "paymentstoacquirepropertyplantandequipment": 246000,
    "netcashprovidedbyusedininvestingactivities": -246000,
    "proceedsfromroyaltypurchaseandsaleagreementnetofissuancecosts": 30600000,
    "proceedsfromissuanceatthemarket": 566000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplans": 112000,
    "proceedsfromstockoptionsexercised": 17000,
    "netcashprovidedbyusedinfinancingactivities": 31333000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 17722000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 48418000,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": 282000,
    "restrictedcash": 160000,
    "restrictedcashandcashequivalents": 160000,
    "restrictedcashassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherAssetsCurrent",
    "royaltypurchaseandsaleagreementissuancecosts": 1900000,
    "entityincorporationdateofincorporation": "May 26, 2011",
    "saleofstocknumberofsharesissuedintransaction": 425460,
    "netproceedsfromissuanceofstock": 600000,
    "initialproceedsfromroyaltysaleandpurchaseagreementnetofcertainexpenses": 32100000,
    "initialproceedsfromroyaltypurchaseandsaleagreement": 32500000,
    "debtrelatedcommitmentfeesanddebtissuancecosts": 1862000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentgross": 1608000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 853000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Lesser ofuseful life orremaininglease term",
    "accruedresearchanddevelopmentexpenses": 1817000,
    "employeerelatedliabilitiescurrent": 1837000,
    "accruedprofessionalfeescurrent": 49000,
    "otheraccruedliabilitiescurrent": 476000,
    "initialproceedsfromroyaltypurchaseandsalesagreement": 32500000,
    "debtrelatedcommitmentfeesanddebtrelatedissuancecosts": 1900000,
    "debtinstrumentinterestrateeffectivepercentage": 0.265,
    "debtinstrumentdescriptionofvariableratebasis": "30-day U.S. LIBOR",
    "debtinstrumentunusedborrowingcapacitydescription": "Of the remaining $10.0 million available under the 2nd A&R loan agreement, the Company elected not to draw $5.0 million and the other $5.0 million was not available for draw",
    "debtinstrumentfinalpaymentpercentage": 0.055,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 3.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The number of shares reserved for issuance under the 2016 ESPP will automatically increase on January 1 of each year, through January 1, 2026, by the lesser of (i) 1% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year, (ii) 454,545 shares of common stock or (iii) a lesser number of shares as may be determined by the Company’s board of directors",
    "sharebasedcompensationarrangementbysharebasedpaymentawardincreaseinnumberofsharesreservedforissuancepercentage": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "commonstockcapitalsharesreservedforfutureissuance": 438572,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.55,
    "commonstockfairmarketvaluepershare": 1.12,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 3100000,
    "allocatedsharebasedcompensationexpense": 31000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9823999999999999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0209,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 580251,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.98,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.35,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.22,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 9,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 20.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 66000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": 7.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 64000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": 6.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 648460,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 375331,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 127544,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 3.44,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 3.04,
    "deferredtaxassetsoperatinglosscarryforwards": 4900000,
    "deferredtaxassetstaxnondeductibleaccrualsaccruedexpenses": 386000,
    "deferredtaxliabilitiesrightofuseassets": 238000,
    "deferredtaxassetsleaseliability": 274000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2678000,
    "deferredtaxliabilitiesdepreciationdifferences": 40000,
    "deferredtaxassetstaxcreditcarryforwards": 326000,
    "royaltypurchasesandsaleagreement": 7247000,
    "deferredtaxassetsinprocessresearchanddevelopment": 3057000,
    "deferredtaxassetsvaluationallowance": 73699000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.0085,
    "effectiveincometaxratereconciliationotheradjustments": -0.0134,
    "effectiveincometaxratereconciliationtaxcredits": 0.021800000000000003,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2157,
    "adjustmenttoprioryeartaxprovision": 0.0067,
    "effectiveincometaxratereconciliationdeductionsother": -0.0009,
    "operatinglosscarryforwards": 78400000,
    "operatinglosscarryforwardsexpirationperiod": 2027,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 7500000,
    "unrecognizedtaxexpenses": 48000,
    "deferredtaxassetsoperatinglossescarryforwardsdomestic": 38000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2000,
    "unrecognizedtaxbenefits": 7520000,
    "lesseeoperatingleaseoptiontoextend": "The renewal option is not included in the calculation of the right-of-use asset and the lease liabilities as the Company is not reasonably certain if the Alpharetta, Georgia lease will be renewed.",
    "incrementalborrowingrate": 0.08,
    "operatingleaseweightedaverageremainingleaseterm1": 4,
    "operatingleasecost": 262000,
    "variableleasecost": 87000,
    "shorttermleasecost": 86000,
    "operatingleasepayments": 339000,
    "operatingleaseliability": 1285000,
    "lesseeoperatingleaseliabilitypaymentsduenextrollingtwelvemonths": 362000,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyeartwo": 378000,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearthree": 389000,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearfour": 367000,
    "operatingleasesfutureminimumpaymentdue": 1496000,
    "operatingleaseimputedinterest": 211000,
    "firstcumulativenetsalesofproducts": 45000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  },
  {
    "date": "2021-12-30",
    "symbol": "CLSD",
    "period": "FY",
    "entityregistrantname": "Clearside Biomedical, Inc.",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CLSD",
    "documenttype": "10-K",
    "entitycentralindexkey": 1539029,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityfilenumber": "001-37783",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "45-2437375",
    "entityaddressaddressline1": "900 North Point Parkway",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Alpharetta",
    "entityaddressstateorprovince": "GA",
    "entityaddresspostalzipcode": 30005,
    "cityareacode": 678,
    "localphonenumber": "270-3631",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Atlanta, Georgia",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 30436000,
    "accountsreceivablenetcurrent": 10000000,
    "prepaidexpensecurrent": 921000,
    "otherassetscurrent": 779000,
    "assetscurrent": 42136000,
    "propertyplantandequipmentnet": 238000,
    "operatingleaserightofuseasset": 369000,
    "restrictedcashandcashequivalentsnoncurrent": 160000,
    "assets": 42903000,
    "accountspayablecurrent": 941000,
    "accruedliabilitiescurrent": 3312000,
    "operatingleaseliabilitycurrent": 387000,
    "deferredrevenuecurrent": 5000000,
    "liabilitiescurrent": 4640000,
    "operatingleaseliabilitynoncurrent": 288000,
    "liabilities": 4928000,
    "commonstockvalue": 60000,
    "additionalpaidincapital": 293406000,
    "retainedearningsaccumulateddeficit": -255491000,
    "stockholdersequity": -255491000,
    "liabilitiesandstockholdersequity": 42903000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 13000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2021-01-31#LicenseMember",
    "researchanddevelopmentexpense": 18537000,
    "generalandadministrativeexpense": 11665000,
    "operatingexpenses": 30202000,
    "operatingincomeloss": -627000,
    "othernonoperatingincome": 1003000,
    "netincomeloss": 376000,
    "earningspersharebasicanddiluted": 0.01,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodvalueatmarketsalesagreement": 12205000,
    "stockissuedduringperiodsharesatmarketsalesagreement": "null",
    "issuanceofcommonsharesvalueunderadirectregisteredoffering": 11078000,
    "issuanceofcommonsharesunderadirectregisteredofferingshares": "null",
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 111000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 65481,
    "stockissuedduringperiodvaluestockoptionsexercised": 388000,
    "stockissuedduringperiodsharesstockoptionsexercised": 280771,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 415268,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 5054000,
    "profitloss": -376000,
    "depreciation": 178000,
    "sharebasedcompensation": 5054000,
    "gainslossesonextinguishmentofdebt": 998000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 10869000,
    "increasedecreaseinotheroperatingcapitalnet": 155000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 681000,
    "increasedecreaseincontractwithcustomerliability": -5000000,
    "netcashprovidedbyusedinoperatingactivities": -10733000,
    "proceedsfromissuanceatthemarket": 12205000,
    "netproceedsafterdeductingofferingexpenses": 11078000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplans": 111000,
    "proceedsfromstockoptionsexercised": 388000,
    "netcashprovidedbyusedinfinancingactivities": 23782000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 13049000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 30696000,
    "forgivenessofpaycheckprotectionprogramloanandaccruedinterest": 998000,
    "restrictedcash": 260000,
    "restrictedcashandcashequivalents": 100000,
    "entityincorporationdateofincorporation": "May 26, 2011",
    "saleofstocknumberofsharesissuedintransaction": 2900000,
    "netproceedsfromissuanceofstock": 12200000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentgross": 1193000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 955000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Lesser ofuseful life orremaininglease term",
    "accruedresearchanddevelopmentexpenses": 1083000,
    "employeerelatedliabilitiescurrent": 1854000,
    "accruedprofessionalfeescurrent": 30000,
    "otheraccruedliabilitiescurrent": 345000,
    "debtinstrumentdescriptionofvariableratebasis": "30-day U.S. LIBOR",
    "debtinstrumentunusedborrowingcapacitydescription": "Of the remaining $10.0 million available under the 2nd A&R loan agreement, the Company elected not to draw $5.0 million and the other $5.0 million was not available for draw",
    "debtinstrumentfinalpaymentpercentage": 0.055,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 4.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The number of shares reserved for issuance under the 2016 ESPP will automatically increase on January 1 of each year, through January 1, 2026, by the lesser of (i) 1% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year, (ii) 454,545 shares of common stock or (iii) a lesser number of shares as may be determined by the Company’s board of directors",
    "sharebasedcompensationarrangementbysharebasedpaymentawardincreaseinnumberofsharesreservedforissuancepercentage": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 201778,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 382788,
    "commonstockcapitalsharesreservedforfutureissuance": 505491,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 5600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.24,
    "commonstockfairmarketvaluepershare": 2.75,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 3500000,
    "allocatedsharebasedcompensationexpense": 61000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.0143,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0075,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 197402,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.93,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.59,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 9,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 20.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 2469000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": 7.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 1880000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": 6.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 965344,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 415268,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.27,
    "deferredtaxassetsoperatinglosscarryforwards": 4800000,
    "deferredtaxassetstaxnondeductibleaccrualsaccruedexpenses": 469000,
    "deferredtaxliabilitiesrightofuseassets": 96000,
    "deferredtaxassetsleaseliability": 176000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2768000,
    "deferredtaxliabilitiesdepreciationdifferences": 44000,
    "deferredtaxassetstaxcreditcarryforwards": 342000,
    "deferredtaxassetscharitablecontributioncarryforwards": 6000,
    "deferredtaxassetsvaluationallowance": 66599000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -5.993200000000001,
    "effectiveincometaxratereconciliationotheradjustments": -0.0315,
    "effectiveincometaxratereconciliationtaxcredits": -2.5397,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 8.478200000000001,
    "effectiveincometaxratereconciliationprioryearincometaxes": -0.0319,
    "adjustmenttoprioryeartaxprovision": -0.1316,
    "effectiveincometaxratereconciliationdeductionsother": 0.039700000000000006,
    "operatinglosscarryforwards": 75600000,
    "operatinglosscarryforwardsexpirationperiod": 2027,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 7500000,
    "unrecognizedtaxexpenses": 48000,
    "unrecognizedtaxbenefits": 7520000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 12000,
    "unrecognizedtaxbenefitsdecreasesresultingfromsettlementswithtaxingauthorities": 36000,
    "lesseeoperatingleaseoptiontoextend": "The renewal option is not included in the calculation of the right-of-use asset and the lease liabilities as the Company has not yet determined if the Alpharetta, Georgia lease will be renewed.",
    "incrementalborrowingrate": 0.11,
    "operatingleaseweightedaverageremainingleaseterm1": 1.75,
    "operatingleasecost": 247000,
    "variableleasecost": 95000,
    "shorttermleasecost": 8000,
    "operatingleaseliability": 675000,
    "lesseeoperatingleaseliabilitypaymentsduenextrollingtwelvemonths": 407000,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyeartwo": 316000,
    "operatingleasesfutureminimumpaymentdue": 723000,
    "operatingleaseimputedinterest": 48000,
    "prelaunchmilestonepayments": 10000000,
    "firstcumulativenetsalesofproducts": 45000,
    "weightedaveragenumberdilutedsharesoutstandingadjustment": 13539,
    "earningspersharebasic": 0.01,
    "earningspersharediluted": 0.01,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  },
  {
    "date": "2020-12-30",
    "symbol": "CLSD",
    "period": "FY",
    "entityregistrantname": "Clearside Biomedical, Inc.",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CLSD",
    "documenttype": "10-K",
    "entitycentralindexkey": 1539029,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-37783",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "45-2437375",
    "entityaddressaddressline1": "900 North Point Parkway",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Alpharetta",
    "entityaddressstateorprovince": "GA",
    "entityaddresspostalzipcode": 30005,
    "cityareacode": 678,
    "localphonenumber": "270-3631",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 17287000,
    "prepaidexpensecurrent": 722000,
    "otherassetscurrent": 109000,
    "assetscurrent": 18118000,
    "propertyplantandequipmentnet": 416000,
    "operatingleaserightofuseasset": 528000,
    "restrictedcashandcashequivalentsnoncurrent": 260000,
    "assets": 19322000,
    "accountspayablecurrent": 1997000,
    "accruedliabilitiescurrent": 1582000,
    "longtermdebtcurrent": 1000000,
    "operatingleaseliabilitycurrent": 373000,
    "deferredrevenuecurrent": 5000000,
    "liabilitiescurrent": 9943000,
    "operatingleaseliabilitynoncurrent": 616000,
    "liabilities": 10559000,
    "commonstockvalue": 52000,
    "additionalpaidincapital": 264578000,
    "retainedearningsaccumulateddeficit": -255867000,
    "stockholdersequity": -255867000,
    "liabilitiesandstockholdersequity": 19322000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 51860941,
    "commonstocksharesoutstanding": 51860941,
    "revenuefromcontractwithcustomerexcludingassessedtax": 200000,
    "typeofrevenueextensiblelist": "clsd:LicenseAndOtherRevenueMember",
    "researchanddevelopmentexpense": 15073000,
    "generalandadministrativeexpense": 10756000,
    "operatingexpenses": 25829000,
    "operatingincomeloss": -17935000,
    "nonoperatingincomeexpense": -275000,
    "netincomeloss": -18210000,
    "earningspersharebasicanddiluted": -0.39,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 46506540,
    "sharesoutstanding": 51860941,
    "stockissuedduringperiodvalueatmarketsalesagreement": 11958000,
    "stockissuedduringperiodsharesatmarketsalesagreement": 6176415,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 31000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 35359,
    "stockissuedduringperiodvaluestockoptionsexercised": 227000,
    "stockissuedduringperiodsharesstockoptionsexercised": 254466,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 981329,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3600000,
    "profitloss": -18210000,
    "depreciation": 180000,
    "sharebasedcompensation": 3600000,
    "paidinkindinterest": 59000,
    "deferredfinancecostsownsharelendingarrangementissuancecostsamortizationexpense1": 129000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1893000,
    "increasedecreaseinotheroperatingcapitalnet": 140000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -631000,
    "netcashprovidedbyusedinoperatingactivities": -13120000,
    "paymentstoacquirepropertyplantandequipment": 55000,
    "netcashprovidedbyusedininvestingactivities": -55000,
    "proceedsfromissuanceatthemarket": 11958000,
    "proceedsfromstockoptionsexercised": 227000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplans": 31000,
    "proceedsfromissuanceoflongtermdebt": 991000,
    "repaymentsoflongtermdebt": 5340000,
    "netcashprovidedbyusedinfinancingactivities": 7867000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -5308000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 17647000,
    "interestpaidnet": 524000,
    "restrictedcash": 360000,
    "entityincorporationdateofincorporation": "2011-05-26",
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentgross": 1193000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 777000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Lesser ofuseful life orremaininglease term",
    "accruedresearchanddevelopmentexpenses": 234000,
    "employeerelatedliabilitiescurrent": 1132000,
    "accruedprofessionalfeescurrent": 56000,
    "otheraccruedliabilitiescurrent": 160000,
    "debtinstrumentdescriptionofvariableratebasis": "30-day U.S. LIBOR",
    "debtinstrumentunusedborrowingcapacitydescription": "Of the remaining $10.0 million available under the 2nd A&R loan agreement, the Company elected not to draw $5.0 million and the other $5.0 million was not available for draw.",
    "debtinstrumentfinalpaymentpercentage": 0.055,
    "interestexpenseborrowings": 7000,
    "accretionoffinalpaymentofamountborrowed": 59000,
    "accretionofdeferredclosingcosts": 129000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P5Y9M",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The number of shares reserved for issuance under the 2016 ESPP will automatically increase on January 1 of each year, through January 1, 2026, by the lesser of (i) 1% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year, (ii) 454,545 shares of common stock or (iii) a lesser number of shares as may be determined by the Company’s board of directors",
    "sharebasedcompensationarrangementbysharebasedpaymentawardincreaseinnumberofsharesreservedforissuancepercentage": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1100250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 201778,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1068601,
    "commonstockcapitalsharesreservedforfutureissuance": 570972,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 3400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.97,
    "commonstockfairmarketvaluepershare": 2.74,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 1000000,
    "allocatedsharebasedcompensationexpense": 41000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P7Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.0813,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0152,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 702041,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 186152,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.31,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.89,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 6.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.96,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 9,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 20.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 2753000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P7Y5M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 1551000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P6Y7M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 767271,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 486000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 981329,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 6700,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 1.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 0.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 0.91,
    "deferredtaxassetsoperatinglosscarryforwards": 2.5,
    "deferredtaxassetstaxnondeductibleaccrualsaccruedexpenses": 263000,
    "deferredtaxliabilitiesrightofuseassets": 132000,
    "deferredtaxassetsleaseliability": 247000,
    "deferredtaxassetsdeferredincome": 1247000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2044000,
    "deferredtaxliabilitiesdepreciationdifferences": 82000,
    "deferredtaxassetstaxcreditcarryforwards": 381000,
    "deferredtaxassetsdisallowedinterestexpense": 7000,
    "deferredtaxassetsvaluationallowance": 63404000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.1428,
    "effectiveincometaxratereconciliationotheradjustments": 0.0142,
    "effectiveincometaxratereconciliationtaxcredits": 0.0289,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.3966,
    "effectiveincometaxratereconciliationprioryearincometaxes": -0.0026,
    "effectiveincometaxratecontinuingoperations": 0.0033,
    "operatinglosscarryforwards": 40700000,
    "operatinglosscarryforwardsexpirationperiod": 2027,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 7600000,
    "unrecognizedtaxbenefitsaccrued": 4600000,
    "unrecognizedtaxexpenses": 48000000000,
    "unrecognizedtaxbenefits": 7568000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 4665000,
    "lesseeoperatingleaseoptiontoextend": "The renewal option is not included in the calculation of the right-of-use asset and the lease liabilities as the Company has not yet determined if the Alpharetta, Georgia lease will be renewed.",
    "incrementalborrowingrate": 0.11,
    "operatingleaseweightedaverageremainingleaseterm1": "P2Y9M",
    "operatingleasecost": 247000,
    "variableleasecost": 95000,
    "shorttermleasecost": 12000,
    "operatingleaseliability": 989000,
    "operatingleasesfutureminimumpaymentsremainderoffiscalyear": 392000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 407000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 316000,
    "operatingleasesfutureminimumpaymentsdue": 1115000,
    "operatingleaseimputedinterest": 126000,
    "assetsfairvaluedisclosure": 17647000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5045260
  },
  {
    "date": "2019-12-30",
    "symbol": "CLSD",
    "period": "FY",
    "entityregistrantname": "Clearside Biomedical, Inc.",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CLSD",
    "documenttype": "10-K",
    "entitycentralindexkey": 1539029,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-37783",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "45-2437375",
    "entityaddressaddressline1": "900 North Point Parkway",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Alpharetta",
    "entityaddressstateorprovince": "GA",
    "entityaddresspostalzipcode": 30005,
    "cityareacode": 678,
    "localphonenumber": "270-3631",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 22595000,
    "prepaidexpensecurrent": 1139000,
    "otherassetscurrent": 1485000,
    "assetscurrent": 25219000,
    "propertyplantandequipmentnet": 541000,
    "operatingleaserightofuseasset": 656000,
    "restrictedcashandcashequivalentsnoncurrent": 360000,
    "assets": 26776000,
    "accountspayablecurrent": 1280000,
    "accruedliabilitiescurrent": 2930000,
    "longtermdebtcurrent": 1333000,
    "operatingleaseliabilitycurrent": 360000,
    "deferredrevenuecurrent": 5000000,
    "liabilitiescurrent": 10903000,
    "longtermdebtnoncurrent": 3819000,
    "operatingleaseliabilitynoncurrent": 897000,
    "liabilities": 15619000,
    "commonstockvalue": 44000,
    "additionalpaidincapital": 248770000,
    "retainedearningsaccumulateddeficit": -237657000,
    "stockholdersequity": -237657000,
    "liabilitiesandstockholdersequity": 26776000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 44413372,
    "commonstocksharesoutstanding": 44413372,
    "revenuefromcontractwithcustomerexcludingassessedtax": 105000,
    "typeofrevenueextensiblelist": "clsd:LicenseAndOtherRevenueMember",
    "researchanddevelopmentexpense": 15658000,
    "generalandadministrativeexpense": 16819000,
    "operatingexpenses": 32477000,
    "operatingincomeloss": -30304000,
    "nonoperatingincomeexpense": -466000,
    "netincomeloss": -30770000,
    "earningspersharebasicanddiluted": -0.81,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 38170830,
    "comprehensiveincomenetoftax": -30770000,
    "sharesoutstanding": 44413372,
    "stockissuedduringperiodvalueatmarketsalesagreement": 10319000,
    "stockissuedduringperiodsharesatmarketsalesagreement": 8976940,
    "stockissuedduringperiodvaluenewissues": 3324000,
    "stockissuedduringperiodsharesnewissues": 3178367,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 45000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 52476,
    "stockissuedduringperiodvaluestockoptionsexercised": 7000,
    "stockissuedduringperiodsharesstockoptionsexercised": 16362,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 70000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4612000,
    "profitloss": -30770000,
    "depreciation": 211000,
    "sharebasedcompensation": 4612000,
    "paidinkindinterest": 163000,
    "deferredfinancecostsownsharelendingarrangementissuancecostsamortizationexpense1": 67000,
    "gainlossonsaleofpropertyplantequipment": -63000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 115000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 558000,
    "increasedecreaseinotheroperatingcapitalnet": 159000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -5582000,
    "increasedecreaseincontractwithcustomerliability": 5000000,
    "netcashprovidedbyusedinoperatingactivities": -27068000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 32950000,
    "paymentstoacquirepropertyplantandequipment": 25000,
    "netcashprovidedbyusedininvestingactivities": 32925000,
    "proceedsfromissuanceatthemarket": 10319000,
    "proceedsfromissuanceofprivateplacement": 3324000,
    "proceedsfromstockoptionsexercised": 7000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplans": 45000,
    "repaymentsoflongtermdebt": 5000000,
    "netcashprovidedbyusedinfinancingactivities": 8695000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 14552000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 22955000,
    "interestpaidnet": 843000,
    "restrictedcash": 360000,
    "entityincorporationdateofincorporation": "2011-05-26",
    "numberofoperatingsegments": 1,
    "shortterminvestmentsmaturityperiodrangestart": "P90D",
    "shortterminvestmentsmaturityperiodrangeend": "P365D",
    "operatingleaseliability": 1257000,
    "propertyplantandequipmentgross": 1138000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 597000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Lesser ofuseful life orremaininglease term",
    "accruedresearchanddevelopmentexpenses": 359000,
    "employeerelatedliabilitiescurrent": 1530000,
    "accruedseverancecosts": 751000,
    "accruedprofessionalfeescurrent": 58000,
    "otheraccruedliabilitiescurrent": 232000,
    "debtinstrumentdescriptionofvariableratebasis": "30-day U.S. LIBOR",
    "longtermdebt": 5000000,
    "lineofcreditfacilityexpirationdate1": "2018-03-31",
    "debtinstrumentpaymentterms": "The Company was required to pay accrued interest only on the outstanding $8.0 million balance through December 31, 2017, followed by 30 equal payments of principal and accrued interest.",
    "prepaymentfeepercentageoforiginalprincipalamountoftheaggregatetermloans": 0.02,
    "debtinstrumentperiodicpaymenttermsballoonpaymenttobepaid": 500000,
    "debtinstrumentmaturitydate": "2020-06-01",
    "debtinstrumentunusedborrowingcapacitydescription": "Of the remaining $10.0 million available under the 2nd A&R loan agreement, the Company elected not to draw $5.0 million and the other $5.0 million is not available for draw.",
    "debtinstrumentfinalpaymentpercentage": 0.055,
    "interestexpenseborrowings": 804000,
    "accretionoffinalpaymentofamountborrowed": 163000,
    "accretionofdeferredclosingcosts": 67000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 1333000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 2000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 1667000,
    "longtermdebtmaturitiesrepaymentsofinterestandfinalpaymentinnexttwelvemonths": 384000,
    "longtermdebtmaturitiesrepaymentsofinterestandfinalpaymentinyeartwo": 219000,
    "longtermdebtmaturitiesrepaymentsofinterestandfinalpaymentinyearthree": 393000,
    "longtermdebtmaturitiesrepaymentsofinterestandfinalpayment": 996000,
    "longtermdebtmaturitiesrepaymentsofprincipalinterestandfinalpaymentinnexttwelvemonths": 1717000,
    "longtermdebtmaturitiesrepaymentsofprincipalinterestandfinalpaymentinyeartwo": 2219000,
    "longtermdebtmaturitiesrepaymentsofprincipalinterestandfinalpaymentinyearthree": 2060000,
    "longtermdebtmaturitiesrepaymentsofprincipalinterestandfinalpayment": 5996000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P6Y9M",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The number of shares reserved for issuance under the 2016 ESPP will automatically increase for a period of ten years, from January 1, 2017 through January 1, 2026, by the lesser of (i) 1% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year, (ii) 454,545 shares of common stock or (iii) a lesser number of shares as may be determined by the Company’s board of directors",
    "sharebasedcompensationarrangementbysharebasedpaymentawardincreaseinnumberofsharesreservedforissuancepercentage": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1920100,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 201778,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 394545,
    "commonstockcapitalsharesreservedforfutureissuance": 658807,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.09,
    "commonstockfairmarketvaluepershare": 2.9,
    "allocatedsharebasedcompensationexpense": 20000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P7Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.0949,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0249,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1262384,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 154901,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.23,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.44,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 9,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 20.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 3191000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P6Y3M25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 1472000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P4Y7M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1269300,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1339300,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 70000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.09,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "deferredtaxassetsvaluationallowance": 56206000,
    "operatinglosscarryforwards": 7600000,
    "deferredtaxassetsoperatinglosscarryforwards": 150000,
    "operatinglosscarryforwardsexpirationperiod": 2027,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 2900000,
    "deferredtaxassetstaxnondeductibleaccrualsaccruedexpenses": 422000,
    "deferredtaxliabilitiesrightofuseassets": 138000,
    "deferredtaxassetsleaseliability": 264000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1472000,
    "deferredtaxliabilitiesdepreciationdifferences": 94000,
    "deferredtaxassetstaxcreditcarryforwards": 623000,
    "deferredtaxassetsdisallowedinterestexpense": 99000,
    "deferredtaxassetscharitablecontributioncarryforwards": 4000,
    "effectiveincometaxratereconciliationotheradjustments": -0.0133,
    "effectiveincometaxratereconciliationtaxcredits": 0.0206,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2173,
    "lesseeoperatingleaseoptiontoextend": "The renewal option is not included in the calculation of the right-of-use asset and the lease liabilities as the Company has not yet determined if the Alpharetta, Georgia lease will be renewed.",
    "incrementalborrowingrate": 0.11,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y9M",
    "operatingleasecost": 393000,
    "variableleasecost": 83000,
    "shorttermleasecost": 20000,
    "operatingleasesfutureminimumpaymentsduecurrent": 378000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 392000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 407000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 316000,
    "operatingleasesfutureminimumpaymentsdue": 1493000,
    "operatingleaseimputedinterest": 236000,
    "assetsfairvaluedisclosure": 22955000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5403546
  }
]